Home › Funds › C WorldWide Group Holding A/S › IOVA
C WorldWide Group Holding A/S position in IOVA
IOVANCE BIOTHERAPEUTICS INC · Health Care
C WorldWide Group Holding A/S reported holding 1,260,000 shares of IOVA (IOVANCE BIOTHERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$18.7M, representing 0.47% of its reported portfolio and ranking #35 among its reported holdings. C WorldWide Group Holding A/S has disclosed IOVA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How C WorldWide Group Holding A/S's IOVA position evolved
C WorldWide Group Holding A/S first disclosed a stake in IOVA in Q3 2023 at 1,360,000 shares (US$6.2M). The position peaked in Q3 2026 at 1,260,000 shares, worth US$18.7M. Across 13 filings, C WorldWide Group Holding A/S increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 10 time(s). The most recent filing (Q3 2026) shows 1,260,000 shares valued at US$18.7M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.36M | $6.19M | New |
| Q4 2023 | 1.36M | $11.06M | Hold |
| Q1 2024 | 1.06M | $15.71M | Reduce |
| Q2 2024 | 1.26M | $10.11M | Add |
| Q3 2024 | 1.26M | $11.83M | Hold |
| Q4 2024 | 1.26M | $9.32M | Hold |
| Q1 2025 | 1.26M | $4.20M | Hold |
| Q2 2025 | 1.26M | $2.17M | Hold |
| Q3 2025 | 1.26M | $2.73M | Hold |
| Q4 2025 | 1.26M | $3.44M | Hold |
| Q1 2026 | 1.26M | $4.42M | Hold |
| Q2 2026 | 1.26M | $5.24M | Hold |
| Q3 2026 | 1.26M | $18.67M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IOVA and 13F data
IOVA (IOVANCE BIOTHERAPEUTICS INC) is a Health Care company. 38 other funds we track also report a position in IOVA — the largest reported positions include MHR FUND MANAGEMENT LLC (US$120.5M), Rhenman & Partners Asset Management AB (US$37.1M), Orion Investment Co (US$30.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IOVA
- MHR FUND MANAGEMENT LLC 28.97M sh · $120.50M · Q2 2026
- Rhenman & Partners Asset Management AB 2.50M sh · $37.09M · Q3 2026
- Orion Investment Co 2.08M sh · $30.88M · Q3 2026
- XCELSIOR ADVISOR PARTNERS LLC 1.84M sh · $27.29M · Q3 2026
- Palo Alto Investors LP 5.30M sh · $22.03M · Q2 2026
- Knott David M Jr 1.17M sh · $17.27M · Q3 2026
- Mirador Capital Partners LP 1.10M sh · $16.24M · Q3 2026
More on C WorldWide Group Holding A/S
FAQ
How long has C WorldWide Group Holding A/S held IOVA?
C WorldWide Group Holding A/S has disclosed IOVA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is C WorldWide Group Holding A/S's current position in IOVA?
As of Q3 2026, C WorldWide Group Holding A/S holds 1.26M shares of IOVA (IOVANCE BIOTHERAPEUTICS INC), valued at $18.67M, representing 0.47% of its reported portfolio and ranking #35.
Has C WorldWide Group Holding A/S been buying or selling IOVA?
In the latest 13F filing (Q3 2026), C WorldWide Group Holding A/S held unchanged its position in IOVA. The position peaked in Q3 2026 at 1.26M shares.
Which other funds hold IOVA?
Other major institutional holders of IOVA include MHR FUND MANAGEMENT LLC, Rhenman & Partners Asset Management AB, Orion Investment Co, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.